Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.